Compare · SBRA vs VTR
SBRA vs VTR
Side-by-side comparison of Sabra Health Care REIT Inc. (SBRA) and Ventas Inc. (VTR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SBRA and VTR operate in Real Estate Investment Trusts (Real Estate), so they compete in similar markets.
- VTR is the larger of the two at $46.72B, about 9.2x SBRA ($5.07B).
- VTR has been more active in the news (14 items in the past 4 weeks vs 2 for SBRA).
- Both have 25 recent analyst ratings on file.
- Company
- Sabra Health Care REIT Inc.
- Ventas Inc.
- Price
- -
- -
- Market cap
- $5.07B
- $46.72B
- 1M return
- -
- +14.57%
- 1Y return
- -
- +44.64%
- Industry
- Real Estate Investment Trusts
- Real Estate Investment Trusts
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 2
- 14
- Recent ratings
- 25
- 25
Sabra Health Care REIT Inc.
As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 Skilled Nursing/Transitional Care facilities, (ii) 64 Senior Housing communities (ÂSenior Housing - LeasedÂ), (iii) 47 Senior Housing communities operated by third-party property managers pursuant to property management agreements (ÂSenior Housing - ManagedÂ) and (iv) 27 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 19 investments in loans receivable (consisting of (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six preferred equity investments and one investment in an unconsolidated joint venture that owns 158 Senior Housing - Managed communities. As of September 30, 2020, Sabra's real estate properties held for investment included 42,378 beds/units and its unconsolidated joint venture included 7,056 beds/units, spread across the United States and Canada.
Ventas Inc.
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries  healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Latest SBRA
- Sabra Health Care REIT downgraded by Truist
- Barclays initiated coverage on Sabra Health Care REIT with a new price target
- Sabra Health Care REIT downgraded by Citigroup with a new price target
- Director Malehorn Jeffrey A. was granted 8,310 shares, increasing direct ownership by 8% to 116,346 units (SEC Form 4)
- Director Kono Ann was granted 8,310 shares, increasing direct ownership by 14% to 68,186 units (SEC Form 4)
- Director Katzmann Lynne S was granted 8,310 shares, increasing direct ownership by 11% to 86,121 units (SEC Form 4)
- Director Foster Michael J was granted 8,310 shares, increasing direct ownership by 11% to 82,043 units (SEC Form 4)
- Director Cusack Catherine was granted 8,310 shares, increasing direct ownership by 11% to 82,056 units (SEC Form 4)
- Director Barbarosh Craig A. was granted 8,310 shares, increasing direct ownership by 15% to 63,326 units (SEC Form 4)
- Sabra Health Care REIT Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
Latest VTR
- Director Smith Maurice S was granted 128 shares, increasing direct ownership by 0.41% to 31,311 units (SEC Form 4)
- Director Embler Michael J was granted 72 shares, increasing direct ownership by 0.37% to 19,274 units (SEC Form 4)
- Director Nader Marguerite M was granted 72 shares, increasing direct ownership by 0.31% to 23,544 units (SEC Form 4)
- Director Roy Sumit was granted 119 shares, increasing direct ownership by 0.48% to 24,872 units (SEC Form 4)
- Director Martino Roxanne M was granted 174 shares, increasing direct ownership by 0.26% to 66,846 units (SEC Form 4)
- Director Lustig Matthew J was granted 281 shares, increasing direct ownership by 0.29% to 95,735 units (SEC Form 4)
- Director Rodriguez Joe Vasquez Jr. was granted 49 shares, increasing direct ownership by 0.49% to 9,943 units (SEC Form 4)
- Director Barnes Melody C was granted 72 shares, increasing direct ownership by 0.20% to 35,379 units (SEC Form 4)
- Barclays initiated coverage on Ventas with a new price target
- Director Smith Maurice S was granted 461 shares, increasing direct ownership by 2% to 31,184 units (SEC Form 4)